| Mrs Amy Filmore Nassar, DNP, APRN, FNP | |
|
2240 M St Nw, Washington, DC 20037-1415 | |
| (866) 389-2727 | |
| Not Available |
| Full Name | Mrs Amy Filmore Nassar |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 2240 M St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124004767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN67989 (District Of Columbia) | Primary |
| Entity Name | Eric C. Marshall Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063644466 PECOS PAC ID: 3779629894 Enrollment ID: O20091005000003 |
News Archive
Mylan Laboratories has announced that the U.S. District Court for the District of Columbia has extended the deadlines pertaining to Mylan's request for a temporary restraining order in its lawsuit seeking to stop the U.S. Food and Drug Administration (FDA) from approving any other Amlodipine Besylate abbreviated new drug applications (ANDAs).
When his wife got Alzheimer's disease, lawyer Ken Chiate invested all his hopes in an unorthodox treatment. Nothing, it seems, could make him give up on it. ... Jeannette's difficulties seemed to emerge out of nowhere. She couldn't grasp the rules of a dice game. She kept asking questions her husband had just answered. ... in 2001, at age 58, she was diagnosed with mild cognitive impairment. As months and years passed, she fell into an angry haze that was determined to be Alzheimer's disease.
Understanding the mechanisms that mediate widespread DNA damage in the cancer genome is of great interest to cancer physicians and scientists because it may lead to improved treatments and diagnosis. In this study, a multi-institutional team led by researchers at Baylor College of Medicine has brought attention to genomic structural variation as a previously unappreciated mechanism involved in altering DNA methylation, a form of gene control, in human cancers.
Perrigo Company today announced that it has agreed to settle its Hatch-Waxman litigation relating to Minoxidil foam brought by Stiefel Research Australia Pty. Ltd., a GSK Company. Under the terms of the settlement, Perrigo can launch in the U. S., a generic version of Men's Rogaine® Foam on March 1, 2012, or earlier under certain circumstances.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amy Filmore Nassar, DNP, APRN, FNP 527 14th St Se, Washington, DC 20003-3012 Ph: (202) 510-5257 | Mrs Amy Filmore Nassar, DNP, APRN, FNP 2240 M St Nw, Washington, DC 20037-1415 Ph: (866) 389-2727 |
News Archive
Mylan Laboratories has announced that the U.S. District Court for the District of Columbia has extended the deadlines pertaining to Mylan's request for a temporary restraining order in its lawsuit seeking to stop the U.S. Food and Drug Administration (FDA) from approving any other Amlodipine Besylate abbreviated new drug applications (ANDAs).
When his wife got Alzheimer's disease, lawyer Ken Chiate invested all his hopes in an unorthodox treatment. Nothing, it seems, could make him give up on it. ... Jeannette's difficulties seemed to emerge out of nowhere. She couldn't grasp the rules of a dice game. She kept asking questions her husband had just answered. ... in 2001, at age 58, she was diagnosed with mild cognitive impairment. As months and years passed, she fell into an angry haze that was determined to be Alzheimer's disease.
Understanding the mechanisms that mediate widespread DNA damage in the cancer genome is of great interest to cancer physicians and scientists because it may lead to improved treatments and diagnosis. In this study, a multi-institutional team led by researchers at Baylor College of Medicine has brought attention to genomic structural variation as a previously unappreciated mechanism involved in altering DNA methylation, a form of gene control, in human cancers.
Perrigo Company today announced that it has agreed to settle its Hatch-Waxman litigation relating to Minoxidil foam brought by Stiefel Research Australia Pty. Ltd., a GSK Company. Under the terms of the settlement, Perrigo can launch in the U. S., a generic version of Men's Rogaine® Foam on March 1, 2012, or earlier under certain circumstances.
› Verified 3 days ago
Ms. Janet E Jumper, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, 4b42, Washington, DC 20010 Phone: 202-877-7462 | |
Arlyne E Heerlein, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Us Dept Ofstate, 2401 E St., Nw, Washington, DC 20522 Phone: 202-663-2453 Fax: 202-663-3247 | |
Seble Yirga, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-7265 Fax: 202-444-4208 | |
Daniel Richard Stairiker, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 202-537-4000 | |
Monica Elston, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw # 3phc, Washington, DC 20007 Phone: 202-444-8531 | |
Sarah Katkhouda, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1627 I St Nw Ste 800, Washington, DC 20006 Phone: 202-204-7092 | |
Ms. Desiree Rivas, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 I St Ne, Washington, DC 20002 Phone: 703-867-2503 |